Concepts (117)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Helicases | 6 | 2017 | 192 | 1.860 |
Why?
|
| Nuclear Proteins | 7 | 2017 | 785 | 1.610 |
Why?
|
| Transcription Factors | 8 | 2017 | 1541 | 1.320 |
Why?
|
| Protein-Arginine N-Methyltransferases | 3 | 2022 | 35 | 0.850 |
Why?
|
| Chromatin Assembly and Disassembly | 5 | 2017 | 233 | 0.710 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2022 | 210 | 0.690 |
Why?
|
| Breast Neoplasms | 3 | 2016 | 1213 | 0.580 |
Why?
|
| Organelle Biogenesis | 1 | 2018 | 18 | 0.570 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2018 | 34 | 0.560 |
Why?
|
| PPAR alpha | 1 | 2018 | 34 | 0.560 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2016 | 73 | 0.550 |
Why?
|
| Chromatin | 3 | 2016 | 616 | 0.490 |
Why?
|
| Carcinogenesis | 1 | 2017 | 130 | 0.480 |
Why?
|
| Cell Proliferation | 2 | 2016 | 1000 | 0.440 |
Why?
|
| Mitochondria | 1 | 2018 | 383 | 0.440 |
Why?
|
| Cell Line, Tumor | 5 | 2022 | 1494 | 0.420 |
Why?
|
| Liver | 1 | 2018 | 868 | 0.400 |
Why?
|
| Neoplasms | 2 | 2022 | 1393 | 0.390 |
Why?
|
| Adipogenesis | 4 | 2016 | 79 | 0.370 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 2 | 2016 | 28 | 0.360 |
Why?
|
| Transcriptional Activation | 2 | 2016 | 191 | 0.340 |
Why?
|
| Oxo-Acid-Lyases | 1 | 2010 | 9 | 0.340 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 667 | 0.340 |
Why?
|
| PPAR gamma | 3 | 2016 | 77 | 0.300 |
Why?
|
| Trans-Activators | 1 | 2010 | 312 | 0.290 |
Why?
|
| Epigenesis, Genetic | 1 | 2010 | 391 | 0.260 |
Why?
|
| Pantoea | 1 | 2006 | 1 | 0.260 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 3 | 2014 | 94 | 0.260 |
Why?
|
| Promoter Regions, Genetic | 4 | 2016 | 685 | 0.260 |
Why?
|
| Zea mays | 1 | 2006 | 30 | 0.250 |
Why?
|
| Genetic Markers | 1 | 2006 | 130 | 0.250 |
Why?
|
| Cholangiocarcinoma | 1 | 2025 | 34 | 0.230 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2025 | 63 | 0.230 |
Why?
|
| Bile Duct Neoplasms | 1 | 2025 | 58 | 0.230 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2006 | 166 | 0.230 |
Why?
|
| Proteomics | 1 | 2006 | 294 | 0.220 |
Why?
|
| Cell Survival | 2 | 2016 | 582 | 0.210 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2016 | 532 | 0.200 |
Why?
|
| Obesity | 1 | 2010 | 1248 | 0.190 |
Why?
|
| Methylation | 1 | 2022 | 131 | 0.180 |
Why?
|
| Mice | 7 | 2025 | 10994 | 0.180 |
Why?
|
| Arginine | 1 | 2022 | 131 | 0.180 |
Why?
|
| Animals | 9 | 2025 | 20955 | 0.180 |
Why?
|
| Bacterial Proteins | 1 | 2006 | 775 | 0.170 |
Why?
|
| Gene Knockdown Techniques | 2 | 2016 | 205 | 0.150 |
Why?
|
| Genetic Loci | 2 | 2016 | 116 | 0.140 |
Why?
|
| Humans | 11 | 2025 | 64272 | 0.140 |
Why?
|
| Diet, High-Fat | 1 | 2018 | 176 | 0.130 |
Why?
|
| Azabicyclo Compounds | 1 | 2016 | 5 | 0.120 |
Why?
|
| Molecular Probes | 1 | 2016 | 31 | 0.120 |
Why?
|
| Lipogenesis | 1 | 2016 | 68 | 0.120 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 96 | 0.120 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2016 | 110 | 0.120 |
Why?
|
| Pyridines | 1 | 2016 | 114 | 0.110 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 423 | 0.110 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 373 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2016 | 644 | 0.100 |
Why?
|
| Lipids | 1 | 2016 | 319 | 0.100 |
Why?
|
| Adenosine Triphosphatases | 1 | 2015 | 256 | 0.100 |
Why?
|
| Cell Cycle | 1 | 2015 | 396 | 0.100 |
Why?
|
| Gene Expression Regulation | 2 | 2018 | 1622 | 0.100 |
Why?
|
| Cell Line | 3 | 2016 | 2057 | 0.100 |
Why?
|
| RNA Interference | 1 | 2016 | 621 | 0.100 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 783 | 0.090 |
Why?
|
| Cytoskeleton | 1 | 2013 | 139 | 0.090 |
Why?
|
| CRISPR-Cas Systems | 1 | 2015 | 364 | 0.090 |
Why?
|
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2010 | 7 | 0.080 |
Why?
|
| DNA Cleavage | 1 | 2010 | 18 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 3449 | 0.080 |
Why?
|
| Mixed Function Oxygenases | 1 | 2010 | 19 | 0.080 |
Why?
|
| Cell Differentiation | 1 | 2016 | 1365 | 0.080 |
Why?
|
| Signal Transduction | 2 | 2018 | 3068 | 0.080 |
Why?
|
| Cell Nucleus | 1 | 2013 | 634 | 0.070 |
Why?
|
| DNA Methylation | 1 | 2010 | 294 | 0.070 |
Why?
|
| Neovascularization, Pathologic | 1 | 2009 | 141 | 0.070 |
Why?
|
| Base Sequence | 1 | 2010 | 1335 | 0.070 |
Why?
|
| Blotting, Southern | 1 | 2006 | 55 | 0.060 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2006 | 40 | 0.060 |
Why?
|
| Plant Leaves | 1 | 2006 | 38 | 0.060 |
Why?
|
| Plant Diseases | 1 | 2006 | 12 | 0.060 |
Why?
|
| Sequence Analysis, Protein | 1 | 2006 | 34 | 0.060 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 929 | 0.060 |
Why?
|
| Blotting, Northern | 1 | 2006 | 150 | 0.060 |
Why?
|
| Virulence | 1 | 2006 | 195 | 0.060 |
Why?
|
| Species Specificity | 1 | 2006 | 334 | 0.060 |
Why?
|
| Female | 3 | 2016 | 33383 | 0.060 |
Why?
|
| Treatment Outcome | 1 | 2016 | 5696 | 0.060 |
Why?
|
| Mass Spectrometry | 1 | 2006 | 303 | 0.060 |
Why?
|
| 3T3-L1 Cells | 2 | 2016 | 90 | 0.060 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 1597 | 0.050 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 1999 | 0.050 |
Why?
|
| Mice, Knockout | 1 | 2025 | 2138 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2013 | 614 | 0.040 |
Why?
|
| Protein Binding | 2 | 2016 | 1619 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2025 | 2237 | 0.040 |
Why?
|
| Male | 1 | 2018 | 30322 | 0.030 |
Why?
|
| Mediator Complex Subunit 1 | 1 | 2016 | 7 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2016 | 340 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2016 | 374 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2016 | 386 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2016 | 436 | 0.030 |
Why?
|
| Protein Transport | 1 | 2016 | 405 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2016 | 268 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 869 | 0.030 |
Why?
|
| Perilipin-1 | 1 | 2014 | 11 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2014 | 22 | 0.030 |
Why?
|
| Adipokines | 1 | 2014 | 32 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2014 | 221 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 235 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2016 | 1160 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2013 | 279 | 0.020 |
Why?
|
| Breast | 1 | 2013 | 190 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 1195 | 0.020 |
Why?
|
| Chick Embryo | 1 | 2009 | 46 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2014 | 709 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2009 | 52 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2013 | 2177 | 0.020 |
Why?
|